Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Principles of method if other than guideline:
Annex V to Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances, published in the Seventeenth Adaption, Commission Directive 92/69/EEC, OJEC L383A, 121-123, 1992.

United States environmental Protection Agency, Health Effects Test Guidelines, OPPTS(1998) 870.1200
GLP compliance:
yes
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine
EC Number:
700-475-0
Cas Number:
145783-14-8
Molecular formula:
C7H7Cl2N3O2S
IUPAC Name:
4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Duration of exposure:
24 h
Doses:
500, 1000, 1500, 2000 mg/kg
No. of animals per sex per dose:
Male: 2000 mg/kg bw. Number of animals: 5
Female: 500, 1000, 1500, 2000 mg/kg bw. Number of animals: 5 in each group
Control animals:
no

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 000 mg/kg bw
Sex:
female
Dose descriptor:
LD50
Effect level:
1 500 mg/kg bw
Sex:
female
Dose descriptor:
LD50
Effect level:
1 000 mg/kg bw
Sex:
female
Dose descriptor:
LD50
Effect level:
500 mg/kg bw
Mortality:
Male: 2000 mg/kg/bw; Number of deaths; 2. Number of animals: 5
Female: 2000 mg/kg/bw; Number of deaths 5; Number of animals: 5
Female: 1500mg/kg/bw; Number of deaths 5; Number of animals: 5
Female 1000 mg/kg/bw; Number of deaths: 4; Number of animals: 5
Female 500 mg/kg/bw; Number of deaths: 0; Number of animals: 5
Clinical signs:
other: Minor clinical signs and signs of skin irritation in surviving animals.
Gross pathology:
Following a dose of 2000 mg/kg, macroscopic abnormalties associated with treatment consisted of scabs in the surviving males and one female. The female had an eye discharge which may also have been treatment-related. Following a dose of 1000 mg/kg to females, the surviving animal had scabs and thickened skin. Following a dose of 500 mg/kg to females, all animals had scabs and thickened skin.

Applicant's summary and conclusion

Interpretation of results:
toxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The acute dermal median lethal dose of UL111 is estimated to be approximately 2000 mg/kg to male rats and 803 mg/kg to female rats. Classified Acute toxicity (dermal) Cat 3 based on estimated LD50 for female rats.